期刊文献+

冠心病患者超敏C-反应蛋白、纤维蛋白原及血尿酸检测分析 被引量:3

下载PDF
导出
摘要 [目的14g讨冠心病(CHD)患者超敏c-反应蛋白(hs—CRP)、纤维蛋白原(Fib)、尿酸(uA)检测的临床应用价值。[方法]对150例冠心病患者(实验组)和150例健康体检者(对照组)分别进行hs—CRP、Fib、UA的检测,并对结果进行比较分析。[结果]CHD患者hs—CRP、Fib、UA含量均显著高于对照组(P〈0.01);CHD各组间hs—CRP、Fib、UA含量差异也有高度显著性(P〈0.01)。[结论]hs—CRP、Fib、UA的检测可作CHD新的实验室诊断指标。
出处 《医学临床研究》 CAS 2012年第12期2434-2435,共2页 Journal of Clinical Research
  • 相关文献

参考文献7

  • 1Torzewski J,Torzewski M,Bowyer DE. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arteriosclerosis,Thrombosis,and Vascular Biology,1998,(09):1386-1392.
  • 2Puddu PE. Serum uric acid for short term prediction of cardiovascular disease incidence in the Gubbio population Study[J].Acta Cardiologica,2001,(04):243-251.doi:10.2143/AC.56.4.2005651.
  • 3Moriarity JT,Folsom AR,Iribarren C. Serum uric acid and risk of coronary heart disease:Atherosclerosis Risk in Communities(ARIC) Study[J].Ann Epidemoil,2000,(03):136-143.
  • 4Yarnell JW,Baker IA,Sweetnam PM. Fibrinogen viscosity,and white blood cell count are major risk factors for ischemic heart disease.The Caerphill and Speedwell collaborative heart disease studies[J].Circulation,1991,(03):836-844.
  • 5李燕,贾青.冠心病患者血脂、血尿酸、血浆纤维蛋白原的测定与分析[J].国际医药卫生导报,2005,11(18):21-22. 被引量:10
  • 6夏鸿剑,刘维波,江隆福,陈国芳.血浆纤维蛋白原和尿酸与冠心病关系的探讨[J].中国医师杂志,2005,7(3):419-420. 被引量:17
  • 7邵超华,王蔚浩.冠心病患者血清尿酸及C-反应蛋白变化水平的临床观察[J].国际医药卫生导报,2005,11(24):46-47. 被引量:4

二级参考文献21

  • 1王雪青.纤维蛋白(原)在动脉粥样硬化发病中的作用及机制[J].生理科学进展,1996,27(3):245-248. 被引量:41
  • 2叶任高.内科学(第5版)[M].北京:人民卫生出版社,2000.159.
  • 3陶美华.冠心病的严重程度与血清C-RP浓度的关系[J].上海医学检验杂志,1991,4:217-218.
  • 4Hamsten A.The hemostatic system and coronary heard diseas[J].Thromb Res,1993,70(1):1-38.
  • 5Freedman DS,Williamson DF,Genter EW,et al.Relation of serum uric acid to morality and ischmic heart disease:The NHANES I Epidemiologic Follow-up Study[J].AMJ Epidimiol,1995,141(7):637-44.
  • 6Guidelines Subcommittee.1999 World Health Organization international society of hypertension guidelines for the management of hypertension[J].J Hyperten,1999,17(2):151-83.
  • 7Guidelines Subcommittee. 1999 World Health Orgnization international society of hypertension gudidelines for the management of hypertension. J Hyperten, 1999,17:151 ~183
  • 8Culleton BF, Larson MG, Kannel WB, et al. Serum uric acidand risk for cardiovascular disease and death:the Framingham study. Ann Intern Med, 1999,131~137
  • 9叶任高 主编.内科学(第5版)[M].北京:人民卫生出版社,2000.428.
  • 10Freedman DS,Williamson DF,Genter EW,et al.Relation of serum acid to mortalily and is chemic heart disease:the NHANESE Epidemiologic Follow-up study[G].

共引文献20

同被引文献21

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部